panaloko us

Earlier this month, the S&P 500 hit a record high of more than 6,000 for the first time ever. Based on that, you might assume that stocks may be too expensive to buy right now as the average stock in the index is trading at more than 25 times earnings. However, there are still many deals out there. Two stocks that could be among the best bargains right now include AbbVie ( ABBV 3.04% ) Comcast ( CMCSA -0.07% ) AbbVie Drugmaker AbbVie isn't having a great year, but it's not having a bad one, either. Its year-to-date gains totaled a modest 7% as of Monday's close. That's decent, but it's nowhere near the S&P 500's more impressive 23% rally. For a while, the stock was outperforming the broad index. However, things went sideways for AbbVie recently after the company reported last week that its schizophrenia drug, emraclidine, failed to meet its primary endpoint in a phase 2 clinical trial. Emraclidine seems to have had the potential to be a blockbuster drug for AbbVie, and investors didn't take the news lightly, dumping the stock afterward. For a diverse business like AbbVie, that is by no means crippling to its operations or long-term outlook. In its most recent quarter, for the period ending Sept. 30, the company reported $14.5 billion in revenue, which grew by nearly 4% year over year -- and that includes a 37% decline in Humira, which recently lost patent protection. AbbVie's diverse business spans immunology, oncology, aesthetics, neuroscience, and eye care. Yet, investors generally recognize that the company is no pushover. Abbvie has historically proven itself to be a growing business. While the pharmaceutical business is inherently risky, and failures will probably show up in Abbvie's pipeline of drug therapies, that itself isn't a reason to turn bearish on what's still a top stock to buy and hold. Eventually, the risk-reward profile is too good to ignore. AbbVie is facing a slowdown right now but the company expects that in 2025 it will "return to robust growth" and that through until the end of the decade, it will grow by high-single digits per year. And while Humira has lost patent protection, the company has effectively replaced that revenue with Skyrizi and Rinvoq, two immunology drugs which it believes will combine for higher peak revenue than its popular rheumatoid arthritis treatment. For investors looking to play the long game, this sell-off can be an opportune time to buy AbbVie on weakness as it trades at a forward price-to-earnings (P/E) multiple of 14, which looks dirt cheap for such a great growth stock . Comcast Comcast hasn't had a huge sell-off recently; it's doing poorly because investors simply haven't seen a big reason to invest in the business this year. Since January, the stock has declined by around 2%. The Summer Olympics gave the company's revenue a bump up in the current quarter as Comcast reported 7% revenue growth for the period ending Sept. 30 (it was down 3% just a quarter earlier), while adjusted earnings per share improved by 3%. But that wasn't enough to get investors excited about the business. It is, after all, just a short-term boost. Heading into next year, however, there could be another growth catalyst to watch out for, and that's the opening of Universal's Epic Universe theme park, which is scheduled for May. Comcast's theme park segment hasn't been doing well this year, as guest attendance is down, and sales declined by 5% for that area of its operations last quarter. Things have slowed after the past couple of years have been record ones for theme parks and keeping up that growth is proving to be a challenge. But the launch of a massive, 750-acre park should spur some excitement in an already-popular tourist area such as Orlando. CEO Brian Roberts says the new park will be "the most ambitious and technologically sophisticated theme park ever created." Strong numbers from the Epic Universe next year could make 2025 an epic year for this underrated stock. And with Comcast recently announcing plans to spin off of its cable networks, the business could be a much better investment moving forward. With those assets accounting for less than 6% of its revenue, it won't make the business drastically smaller but it could help with its potential in the long run, by being able to divert more funds and resources into more attractive growth opportunities (such as theme parks). Comcast is trading at an incredibly low forward P/E of 10 and it could make for an excellent contrarian buy right now.

Are you tracking your health with a device? Here’s what could happen with the dataAaron Rodgers: 'I'm Always Available' If Jets Want My Input on HC, GM SearchesPrince Harry and Meghan Markle snubbed from Selfridges Christmas bauble collection

Standard Motor Products Releases 2,367 New Numbers in 2024

Blinken faces GOP critics in Congress who say Afghanistan withdrawal 'lit the world on fire'

The Indigenous ancestry of the Métis Nation of Ontario’s (MNO) chair is being brought into question. While currently on leave as he deals with health issues, reports provided to MidlandToday suggest Hank Rowlinson doesn’t have any actual First Nation, Métis or Inuit blood. Rowlinson, who grew up in Sault Ste. Marie and now lives with his wife in Sudbury, says these allegations are false and that he has hired an investigator to track down the perpetrators. “It’s a drive-by smear campaign,” Rowlinson tells MidlandToday during a phone interview. “It’s not the first time. I’m just the flavour of the month they’re going after. Somebody started with false information and it’s like everything — it snowballs.” Last month, “expert genealogist” Cindy Cook sent MidlandToday a family tree and other documentation that she says shows that Rowlinson has no Indigenous roots. “I have thoroughly vetted this information,” she says. “I live where the chair of the MNO was raised and know his family and know that he is in no way Aboriginal.” In a social media post, Indigenous activist Crystal Semaganis says she and Rowlinson have many common friends and he is, by all accounts, a “popular” guy. “Everyone figures that because he is chair of the Métis Nation of Ontario and you’ve seen him at recent events like the MNO’s Annual Grifters Assembly . . . I mean AGA . . . everyone is going to assume this man is Métis. “He is not, not one drop of FNMI blood -- like the majority of the MNO is . . . not even Métis.” Semaganis says her organization, the Ghost Warrior Society, estimates that only 15 per cent of MNO members “are actually Red River. Forty per cent are non-status descendants of a First Nation, and the rest are straight-up settlers like Henry here.” When it comes to Rowlinson, Semaganis says an ancestry profile shows that his father was Serbian and there are no Indigenous descendants on his mother’s side. “Shake that tree as hard as you want, and nothing but settlers falls out of that tree.” But Rowlinson says those raising concerns don’t have the proper information regarding his ancestry. “My great-grandmother and great-grandfather hail from Manitoba. That’s where I get my Métis ancestry from. They got scrip,” he says, noting Alfred Oliver Roy and Kathy Amandière (sp.) were from St. Norbert, Man. “If they had the proper information on my ancestry and know the history of my family, they would obviously not be targeting me.” Rowlinson says he’s satisfied the citizen requirements of the MNO and that “I’ve proven myself through a third-party registry, Know History.” Once his investigator tracks down the names and addresses of those who are saying he’s not Métis, Rowlinson says his lawyer will file a “libel, slander and defamation lawsuit against everybody involved.” Rowlinson says the MNO takes ensuring the legitimacy of its registry seriously. “With the Métis Nation of Ontario, we have a third-party registrar. There’s no political interference. We’ve just gone through an in-depth review of everybody’s file.” Rowlinson says he doesn’t understand why the MNO is being targeted by various groups, including the Manitoba Métis Federation and Chiefs of Ontario, which held a conference highlighting what it sees as Indigenous identity fraud earlier this year. Adds Rowlinson: “If they had the education (they wouldn’t). You can’t change the facts of history.” Semaganis, meanwhile, is irked that the MNO continues to receive large amounts of annual funding since it’s “tight with (Premier) Doug Ford to keep the money train going. Disgusting.” The MNO receives close to $150 million in annual funding from the provincial and federal governments, something that upsets Semaganis, who is originally from Saskatchewan but now lives in Ontario. “They have more funding and programs, post-secondary education dollars than a Status Indian does in Ontario and probably more than any in Canada.” Until recently, the Ghost Warrior Society listed people across the country, who it determined weren’t actually Indigenous. It still offers resources for those looking to uncover what it calls ‘Pretendians’ along with a cartoon bear video . On its website, the MNO notes that Rowlinson has more than 25 years of full-time experience working various roles within the MNO. “A steadfast advocate for the Métis, Hank brings commitment, experience and determination that is needed as we enter into an era of self-government,” the MNO notes. “Respecting our statement of prime purpose, Hank believes that the way forward needs to be one of hope, optimism and vigilance and that we must be united to overcome barriers that may stand in our way.” Last year, the MNO featured 19 people on the province‘s so-called Sunshine List , with Rowlinson receiving $120,800 in compensation.

NoneStandard Motor Products Releases 2,367 New Numbers in 2024Radio Erena: Eritrea’s voice of hope under threat

LA PAZ, Bolivia — Bolivia's highest court on Wednesday approved the extradition to the United States of a former anti-narcotics chief on charges of conspiring to smuggle cocaine into the U.S., a rare ruling against a top security official in the Andean nation whose relations with Washington have been strained for decades. The decision, which cannot be appealed, caps the rapid downfall of Maximiliano Dávila, 59, Bolivia's top drug cop in 2019 under former leftist President Evo Morales, the first Indigenous president of Bolivia who became a global anti-imperialist icon for kicking out the U.S. ambassador and Drug Enforcement Administration in 2008. A former police colonel, Dávila was indicted in 2022 in New York on federal charges of conspiring to import cocaine to the U.S. and possessing machine guns. The indictment accused Dávila of leveraging his position to provide top-level protection to cargo planes transporting cocaine through third countries for distribution in the U.S. The Justice and State Departments also offered a reward of up to $5 million for information leading to his conviction. Dávila official has denied the charges. Bolivia’s Supreme Court of Justice announced it was granting a formal U.S. request for Dávila to be extradited on drug conspiracy charges. The U.S. State Department and Department of Justice did not publicly comment on the announcement. Get the latest breaking news as it happens. By clicking Sign up, you agree to our privacy policy . “After reviewing the documentation and the corresponding evidence, it has been determined to proceed immediately with Dávila’s extradition,” said Marco Jaimes, the court's president. Inside Bolivia, Dávila is facing money laundering charges. Bolivian authorities arrested him in 2022 as he was allegedly fleeing to Argentina, hauling him to jail in the capital of La Paz where he now remains. Dávila led the anti-narcotics agency in Bolivia for the final nine months of Morales’ 14-year presidency, which ended abruptly in November 2019. The powerful former coca farmer resigned as street protests erupted after the announcement that he had won re-election to an unprecedented fourth term. The interim government of Jeanine Áñez, which took power following Morales' ouster, sacked Dávila. But he returned in 2020 under the government of President Luis Arce, Morales' former economy minister. Dávila served for a year as police commander in Bolivia's central region of Cochabamba, a key hub of the country's coca-leaf production. An extradition treaty between Bolivia and the U.S. has been in force since 1995, despite decades of uneasy relations marked by America’s “war on drugs” and Morales' fierce opposition as a young union leader to U.S. forcible coca eradication policies. After Morales expelled the U.S. ambassador in 2008, the Bush administration did the same and nothing has changed since. This is the second time in Bolivian history that authorities have approved the extradition to the U.S. of a senior security officer, said Saul Lara, an opposition lawmaker and ex-foreign minister. The first was in 1995, when Col. Faustino Rico Toro, a former interior minister and anti-drug chief close to brutal Bolivian dictator Luis Garcia Meza, was handed over to U.S. authorities in Miami on cocaine trafficking charges. From Bolivia, lawyers for Dávila vowed to challenge the extradition. “This is a serious violation of human rights,” said defense attorney Manolo Rojas, promising that he would raise the case with the Inter-American Commission on Human Rights, an organ of the Organization of American States, of which the U.S. is a founding member. Bolivia's court decision comes as a fierce rivalry escalates between current President Arce and former President Morales, tearing apart the ruling Movement Toward Socialism party ahead of 2025 elections. Although Morales insists he has nothing to do with Dávila, Arce's supporters have sought to portray Wednesday's ruling against his former minister as a blow to the political career of the ex-president who seeks to run in the presidential elections next year despite a court ban. “In the United States, the former anti-drug czar will surely be able to reveal who his accomplices are. Perhaps it is Evo,” said Senator Virginia Velasco, referring to Morales without elaborating.